Omega-3 supplements market to reach $17.21 billion by 2030 at 11.7% cagr, driven by rising prevalence of cardiovascular diseases.
Read More
Omega 3 prescription drugs market to reach $2.81 billion by 2030 at 10.0% cagr, driven by rising cases of cardiovascular diseases.
Read More
Oligonucleotide therapy market to reach $10.87 billion by 2030 at 12.0% cagr, driven by government initiatives for research and development in healthcare.
Read More
Olanzapine market to reach $3.11 billion by 2030 at 3.6% cagr, driven by increasing prevalence of emotional illness and mental troubles.
Read More
The global octreotide market to reach $3.26 billion by 2030 at 4.9% cagr, driven by increasing rates of cancer.
Read More
Occupational medicines market to reach $7.61 billion by 2030 at 7.1% cagr, driven by increasing prevalence of chronic diseases among the working population.
Read More
Obeticholic acid market to reach $1.84 billion by 2030 at 12.7% cagr, driven by rising prevalence of liver diseases.
Read More
Nutritional supplements market to reach $635.59 billion by 2030 at 7.2% cagr, driven by increasing health and fitness awareness.
Read More
Nutritional serum market to reach $10.23 billion by 2030 at 8.4% cagr, driven by growing focus on personal care and beauty.
Read More
Nutraceutical excipients market to reach $5.78 billion by 2030 at 6.0% cagr, driven by growing demand for health and wellness.
Read More